Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology entities : Jaguar health, inc. save search
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 26.26%
H: 73.2%
C: 18.87%
health cancer care for commercial
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 7.14%
H: 1.11%
C: -8.89%
health granted extension
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -4.68%
H: 0.82%
C: 0.82%
health international
Jaguar Health Reports 2023 Financial Results
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -14.35%
health financial results
Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief
Published: 2024-02-14 (Crawled : 15:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -0.24%
H: 1.1%
C: -0.73%
health direct
Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea
Published: 2024-02-12 (Crawled : 14:30) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 6.09%
H: 7.88%
C: 0.68%
fda drug diarrhea health designation application crofelemer submission
Jaguar Health to Present January 31 at The Microcap Conference and Participate in a Fireside Chat February 1 at the Lytham Partners Investor Select Conference
Published: 2024-01-29 (Crawled : 15:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -3.2%
H: 0.37%
C: -4.13%
conference health microcap
A Majority of Subjects in Jaguar Health's Placebo-Controlled Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Chose to Continue on to Stage II
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -15.16%
H: 1.78%
C: -18.62%
diarrhea cancer trial therapy
Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website
Published: 2023-12-06 (Crawled : 14:30) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 0.03%
H: 1.67%
C: -1.27%
breast health life symposium cancer pharmaceuticals family study
Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference
Published: 2023-11-30 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 1.83%
H: 7.34%
C: -0.84%
conference health
Jaguar Health Reports Third Quarter 2023 Financial Results
Published: 2023-11-14 (Crawled : 13:30) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 6.48%
H: 3.76%
C: 0.42%
health financial results
Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 2.98%
H: 9.47%
C: 8.06%
health
REMINDER: Jaguar Health to Host Virtual Educational Webinar on Rare Intestinal Failure Diseases with Leading Gastroenterologists and Nutrition Experts November 8th from 1:00 PM to 2:30 PM EST
Published: 2023-11-07 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -1.96%
H: 7.69%
C: 0.58%
rare nutrition health
Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 1.7%
H: 3.0%
C: -9.45%
rare health license revenue pharmaceuticals commercialization crofelemer agreement store
Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Published: 2023-11-01 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 1.45%
H: 1.57%
C: -1.0%
patent health treatment
Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet
Published: 2023-10-30 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 1.97%
H: 5.97%
C: 2.63%
health one funding
Jaguar Health to Present November 1st at Emerging Growth Conference
Published: 2023-10-26 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -6.08%
H: 6.42%
C: 4.56%
conference health growth
Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications
Published: 2023-10-23 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -2.61%
H: 2.86%
C: 1.49%
health treat preclinical adhd study
Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
Published: 2023-10-18 (Crawled : 13:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: -4.27%
H: 8.4%
C: 5.92%
drug conference association care pharmaceuticals
Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
Published: 2023-10-12 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 102.48%
H: 7.96%
C: -27.76%
conference health
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.